[ PT | EN ]

Everything the press needs to know about HiLab

Materials, numbers, news, and why we do what we do.

We were born in 2004

Friends and entrepreneurs, Marcus Figueredo and Sérgio Rogal founded Hi Technologies, now known as HiLab, a company that specializes in health tech.

In 2017, we created the HiLab service

Our lab testing service was born to expand access to healthcare to more people, with portable telemedicine devices that make diagnoses possible anywhere!

We operate in different segments

Pharmacies, Public Health, Clinics, Laboratories, Companies and Health Insurance Companies.

A little bit of our 2020...

We reached more than

$
40million

in sales

We grew

50X

the number of clients and our capacity to produce and report exams

We were valued at

R$
300M

when we participated in an investment round that took place in February 2020

So far...

We performed more than

4 million

exams

In more than

4000

places

We want to democratize people's access to healthcare, through the reinvention and humanization of diagnostic technology

Currently, 50% of the Brazilian population is less than 6km away from a HiLab device and more than 2 million people have already taken one of our exams.

Stories that make us proud

In March 2020, we were the first company in Brazil to launch a coronavirus test with results in minutes and a report signed by experts.

We created the Hilab Molecular, the first molecular biology testing device with results within 1 hour.

We participated with the Brazilian Federal Government in the Kayapó Mission in the north of the country, which took telemedicine to remote areas such as indigenous villages.

We participated in the Favela sem Corona (Favela without Corona) action in Rocinha, carrying out tests with community residents, which helped to detect positive cases and raise awareness among the population.

We co-developed the Tainá Platform, used by the Butantan Institute to centralize and manage epidemiological and vaccination data during the COVID-19 pandemic.

Plataforma Tainá

We collaborated on Project S, the first clinical study in the world for the effectiveness of CoronaVac in reducing the transmission of COVID-19, in partnership with Butantan Institute and the city of Serrana, in the state of São Paulo.

Between February and April, we maintained a 2.35% positivity with our mass testing strategy for COVID-19 at HiLab.

COVID-19 testing of Petrobras’ SIX and REPAR refineries employees since March 2021.

In April 2021, we launched the HiLab Testing Space for COVID-19 at Afonso Pena Airport in Curitiba.

In March 2020, we were the first company in Brazil to launch a coronavirus test with results in minutes and a report signed by experts.

We participated with the Brazilian Federal Government in the Kayapó Mission in the north of the country, which took telemedicine to remote areas such as indigenous villages.

We co-developed the Tainá Platform, used by the Butantan Institute to centralize and manage epidemiological and vaccination data during the COVID-19 pandemic.

Between February and April, we maintained a 2.35% positivity with our mass testing strategy for COVID-19 at HiLab.

In April 2021, we launched the HiLab Testing Space for COVID-19 at Afonso Pena Airport in Curitiba.

We created the Hilab Molecular, the first molecular biology testing device with results within 1 hour.

We participated in the Favela sem Corona (Favela without Corona) action in Rocinha, carrying out tests with community residents, which helped to detect positive cases and raise awareness among the population.

We collaborated on Project S, the first clinical study in the world for the effectiveness of CoronaVac in reducing the transmission of COVID-19, in partnership with Butantan Institute and the city of Serrana, in the state of São Paulo.

COVID-19 testing of Petrobras’ SIX and REPAR refineries employees since March 2021.

Spokespersons who can tell you more about HiLab

Marcus Vinícius
Mazega Figueredo

CEO

Bernardo Montesanti Machado de Almeida
Chief Medical Officer

Jose Restrepo
Chief Marketing Officer

Our team

More than

400

employees

More than

62%

of women

More than

50%

women in leadership positions

More than

19%

are part of the LGBTQIA+ community

More than

14%

are studying or have completed a master's or doctoral degree